MYGN Financial Facts

Cost of molecular diagnostic testing: 34.3M
Research and development expense: 19.4M
See Full Income Statement

Total current assets: 322.9M
Unrecognized tax benefits: 24.4M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

| Expand Research on MYGN

Next EPS Date	5/2/24	EPS Growth Rate	N/A
Average EPS % Beat Rate	+96.9%	Revenue Growth Rate	N/A
Average % Move 1-Wk after EPS	-2.4%	Normal Earnings Time	After Close

Date	Qtr	EPS	Cons.	Surprise	Revs	Cons.	Gd.	1-Week %	1-Day %	Details
5/7/18	Q318	N/A	$0.27	N/A	N/A	$188.22M	=	N/A	N/A
11/4/19	Q120	$0.08	$0.32	-$0.24	$186.3M	$202.1M				Details
11/1/22	Q322	-$0.19	-$0.06	-$0.13	$156.4M	$170.58M				Details
5/5/20	Q320	-$0.08	$0.02	-$0.10	$164M	$167.19M				Details
2/6/20	Q220	$0.23	$0.31	-$0.08	$195.1M	$209.81M				Details
11/4/14	Q115	$0.25	$0.32	-$0.07	$168.8M	$175M	=			Details
8/9/16	Q416	$0.32	$0.38	-$0.06	$186.5M	$187.92M	=			Details
8/13/19	Q419	$0.41	$0.47	-$0.06	$215.4M	$221.04M				Details

2/5/19	Q219	$0.38	$0.41	-$0.03	$216.8M	$216.73M	=			Details
11/1/16	Q117	$0.23	$0.25	-$0.02	$177.5M	$172.85M	=			Details
8/11/15	Q415	$0.41	$0.42	-$0.01	$189.9M	$187.77M	=			Details
8/3/23	Q223	-$0.08	-$0.08	$0.00	$183.5M	$187.07M	=			Details
11/2/21	Q321	-$0.02	-$0.02	$0.00	$167.3M	$165.04M	N/A			Details
2/23/21	Q221	-$0.12	-$0.12	$0.00	$154.6M	$150.39M	N/A			Details
1/27/11	Q211	$0.26	$0.26	$0.00	$100.4M	$98.84M				Details
8/14/12	Q212	$0.34	$0.34	$0.00	$133M	$131.85M	=			Details
11/1/11	Q112	$0.29	$0.28	+$0.01	$110.5M	$106.49M	=			Details
5/5/15	Q315	$0.40	$0.39	+$0.01	$180M	$183.3M	=			Details
8/9/11	Q411	$0.30	$0.29	+$0.01	$107.4M	$104.43M	=			Details
11/2/10	Q111	$0.24	$0.23	+$0.01	N/A	N/A				Details
1/31/12	Q212	$0.33	$0.31	+$0.02	$122.8M	$115.28M	=			Details
5/1/12	Q112	$0.34	$0.32	+$0.02	$129.8M	$119.2M	=			Details
8/12/14	Q414	$0.48	$0.46	+$0.02	$188.8M	$187.68M	=			Details
2/7/17	Q217	$0.26	$0.24	+$0.02	$196.5M	$189.72M	=			Details
2/27/24	Q423	$0.04	$0.01	+$0.03	$196.6M	$194.8M	N/A			Details
5/6/14	Q314	$0.48	$0.45	+$0.03	$176.2M	$175.23M	=			Details
5/3/16	Q316	$0.41	$0.38	+$0.03	$190.5M	$184.92M	=			Details
5/2/17	Q317	$0.27	$0.23	+$0.04	$196.9M	$189.1M	=			Details
5/7/19	Q319	$0.46	$0.42	+$0.04	$216.6M	$217.46M	=			Details
2/28/23	Q422	-$0.12	-$0.16	+$0.04	$177.8M	$169.47M	=			Details
8/8/17	Q417	$0.30	$0.26	+$0.04	$200.5M	$193.74M	=			Details
2/5/13	Q213	$0.42	$0.38	+$0.04	$149.1M	$143.71M				Details
11/5/12	Q113	$0.36	$0.32	+$0.04	$133.44M	$129.43M				Details
2/2/16	Q216	$0.45	$0.41	+$0.04	$193.3M	$189.97M	=			Details
11/7/17	Q118	$0.26	$0.21	+$0.05	$190.2M	$183.38M	=			Details
8/21/18	Q418	$0.38	$0.33	+$0.05	$200.9M	$195.76M	=			Details
2/3/15	Q215	$0.40	$0.35	+$0.05	$184.4M	$183.41M	=			Details
11/6/23	Q323	-$0.03	-$0.08	+$0.05	$191.9M	$179.23M	=			Details
11/3/15	Q116	$0.41	$0.35	+$0.06	$183.5M	$177.89M	=			Details
5/7/13	Q113	$0.46	$0.40	+$0.06	$156.5M	$148.25M				Details
5/3/11	Q311	$0.31	$0.25	+$0.06	$102.4M	$98.11M				Details
2/6/18	Q218	$0.31	$0.24	+$0.07	$194M	$188.8M	=			Details
5/3/21	Q321	-$0.06	-$0.14	+$0.08	$173.1M	$156.2M	N/A			Details
10/31/23	Q323	N/A	-$0.08	N/A	N/A	$179.23M	=	N/A	N/A
8/13/13	Q413	$0.53	$0.44	+$0.09	$174.1M	$159.87M	=			Details
8/4/22	Q222	$0.12	$0.03	+$0.09	$189.4M	$170.96M				Details
5/2/24	Q124	N/A	-$0.10	N/A	N/A	$193.26M	N/A	N/A	N/A
11/6/18	Q119	$0.43	$0.30	+$0.13	$202.3M	$202.37M	=			Details
11/9/20	Q121	-$0.15	-$0.30	+$0.15	$145.2M	$135.21M	N/A			Details
2/23/23	Q422	N/A	-$0.16	N/A	N/A	$169.47M		N/A	N/A
8/13/20	Q420	-$0.31	-$0.47	+$0.16	$93.2M	$93.85M	N/A			Details
5/3/23	Q123	N/A	-$0.19	N/A	N/A	$171.55M	=	N/A	N/A
2/4/14	Q214	$0.66	$0.46	+$0.20	$204.06M	$176.02M	=			Details
8/3/21	Q421	$0.12	-$0.09	+$0.21	$189.4M	$165.4M				Details
11/5/13	Q114	$0.68	$0.46	+$0.22	$202.47M	$167.64M	=			Details

MYGN Financial Facts

Myriad Genetics Inc. (MYGN) Earnings

Free News Feed